Hepatic molecular circadian clock

The hepatic molecular circadian clock is a cell-autonomous timing system in hepatocytes composed of interlocking transcription-translation feedback loops that synchronize liver metabolism with daily environmental and nutritional cycles. The core machinery is driven by the transcriptional activators CLOCK and BMAL1, which initiate the expression of their own repressors, the Period (PER1/2/3) and Cryptochrome (CRY1/2) proteins, resulting in approximately 24-hour oscillations. A critical secondary regulatory limb involves the nuclear receptors REV-ERBα/β and RORα/β/γ, which link the core clock to vital metabolic pathways including lipid and glucose homeostasis, bile acid synthesis, and inflammatory responses. Dysfunction or desynchrony of the hepatic clock is strongly associated with metabolic disorders such as non-alcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes. Therapeutic modulation of these clock components, particularly through REV-ERB agonists or CRY stabilizers, aims to restore rhythmic metabolic output and attenuate disease progression. However, such interventions face challenges related to chronotoxicity and the potential for systemic circadian disruption.

Other names

Hepatic circadian clockLiver molecular clockCircadian clock machineryCore clock feedback loopNuclear receptor subfamily 1 group D member 1 (REV-ERB alpha)Cryptochrome circadian regulator (CRY1/2)Brain and muscle ARNT-like protein 1 (BMAL1)

Pharmacological modulation of the hepatic circadian clock involves targeting core proteins within the transcription-translation feedback loops (TTFLs). Key mechanisms include agonism or antagonism of the nuclear receptors REV-ERBα/β to repress BMAL1 transcription, stabilization of Cryptochromes (CRY1/2) to prolong the repressive phase of the clock cycle, and activation of ROR receptors to enhance clock gene expression and metabolic throughput.